Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P De Schepper

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1996
Combination analgesic involvement in the pathogenesis of analgesic nephropathyP Michielsen, P De Schepper
The New England Journal of Medicine|July 11, 1998
Analgesic nephropathyP Michielsen, P De Schepper
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1996
Analgesic nephropathy in Belgium: confusion between prevalence and incidenceP Michielsen, P De Schepper
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Pharmacokinetics of fleroxacin determined by biological methodL Verbist, A Van Hecken, P De Schepper
Archives Internationales De Physiologie Et De Biochimie|April 1, 1976
Effect of chlorpropamide on hepatic triglyceride metabolismL Debeer, J Thomas, G Mannaerts, et al.
The Journal of Clinical Pharmacology and New Drugs|January 1, 1973
Cephradine absorption and excretion in fasting and nonfasting volunteersC Harvengt, P De Schepper, F Lamy, et al.
Archives Internationales De Physiologie Et De Biochimie|April 1, 1976
Antilipolytic effect of chlorpropamide in isolated rat hepatocytesL Debeer, J Thomas, G Mannaerts, et al.
European Urology|January 1, 1991
Hormonal effects of a 5 alpha-reductase inhibitor (finasteride) on hormonal levels in normal men and in patients with benign prostatic hyperplasiaA Vermeulen, V A Giagulli, P De Schepper, et al.
The Journal of Clinical Pharmacology and New Drugs|February 1, 1973
Pharmacologic study of cefazolin in volunteersP De Schepper, C Harvengt, C Vranckx, et al.
The Prostate|January 1, 1989
Hormonal effects of an orally active 4-azasteroid inhibitor of 5 alpha-reductase in humansA Vermeulen, V A Giagulli, P De Schepper, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1996
Combination analgesic involvement in the pathogenesis of analgesic nephropathyP Michielsen, P De Schepper
The New England Journal of Medicine|July 11, 1998
Analgesic nephropathyP Michielsen, P De Schepper
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1996
Analgesic nephropathy in Belgium: confusion between prevalence and incidenceP Michielsen, P De Schepper
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Pharmacokinetics of fleroxacin determined by biological methodL Verbist, A Van Hecken, P De Schepper
Archives Internationales De Physiologie Et De Biochimie|April 1, 1976
Effect of chlorpropamide on hepatic triglyceride metabolismL Debeer, J Thomas, G Mannaerts, et al.
The Journal of Clinical Pharmacology and New Drugs|January 1, 1973
Cephradine absorption and excretion in fasting and nonfasting volunteersC Harvengt, P De Schepper, F Lamy, et al.
Archives Internationales De Physiologie Et De Biochimie|April 1, 1976
Antilipolytic effect of chlorpropamide in isolated rat hepatocytesL Debeer, J Thomas, G Mannaerts, et al.
European Urology|January 1, 1991
Hormonal effects of a 5 alpha-reductase inhibitor (finasteride) on hormonal levels in normal men and in patients with benign prostatic hyperplasiaA Vermeulen, V A Giagulli, P De Schepper, et al.
The Journal of Clinical Pharmacology and New Drugs|February 1, 1973
Pharmacologic study of cefazolin in volunteersP De Schepper, C Harvengt, C Vranckx, et al.
The Prostate|January 1, 1989
Hormonal effects of an orally active 4-azasteroid inhibitor of 5 alpha-reductase in humansA Vermeulen, V A Giagulli, P De Schepper, et al.
Pageof 2